In a report published Wednesday, Morgan Stanley analyst Dara Mohsenian reiterated an Underweight rating and $85.00 price target on The Clorox Co. CLX.
In the report, Morgan Stanley noted, “We remain UW [on] CLX given we believe weak US consumer spending, heightened competition with incremental promotion, and Venezuela/Argentina risk, will limit near-term results, which is not fully reflected in valuation, particularly given CLX's long-term EPS growth potential is below peers.”
The Clorox Co. closed on Tuesday at $85.81.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in